Instead of squawking nonsense at me (for my long term unchanged position) perhaps consider reaching out the to company and asking:
Why did it take 18 months to recruit a patient in p1b?
Why was the trial halted in 2024 with no updates provided to shareholders since 2023?
Why didn't management investigate low dose mono/combination therapy given the data produced in p1a?
Ann: 1st Australian site activated PD1-Vaxx Neo-POLEM Ph II trial, page-38
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $99.01K | 6.946M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 79 | 15179155 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 213471 | 1 |
View Market Depth
| Last trade - 15.59pm 16/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |